Objective: To investigate the variation of t cell subsets and soluble interleukin 2 recepter (SIL 2r) in patients with malignant tumors.
目的：探讨恶性肿瘤患者T细胞亚群及可溶性白细胞介素2 (SIL 2r)的变化。
The T cells subgroup absolute count and the NK activity of malignant tumor patient's PBMC can be obviously elevated by transfusing CD3AK cell.
CD3AK细胞输注能明显提高肿瘤患者外周血T淋巴细胞亚群绝对计数和PBMC的NK活性。
Objective:To study the effects of cord blood transfusion on the hematopoietic function and T cell in gynecologic malignant tumor patients with chemotherapy.
目的：本研究采用了随机对照实验对脐血输注后妇癌患者外周血造血功能恢复及T细胞亚群的变化及其机理进行探讨。
Objective: To observe the expression of protein phosphotyrosine phosphatase SHP-1 in malignant t and NK cell lymphomas.
目的探讨蛋白酪氨酸磷酸酶SHP - 1在T与NK细胞淋巴瘤中的表达。
It may provide malignant tumor cells with mechanisms to escape from T-cell recognition and destruction.
这提供了人类肿瘤细胞逃避T细胞介导免疫识别和破坏的途径之一。
OBJECTIVE: To observe the effect of large dose mannatide on T-cell subpopulatations and healthy condition of patients with Malignant Lymphoma.
目的：探讨大剂量甘露聚糖肽对恶性淋巴瘤患者免疫功能及健康状况的影响。
Objective: To assess the influence of chemotherapeutics on T cellular immunity and T cell subsets excluding the influence of malignant tumors.
目的：探讨化疗药物对T淋巴细胞及其亚群的影响。
Objective: To assess the influence of chemotherapeutics on T cellular immunity and T cell subsets excluding the influence of malignant tumors.
目的：探讨化疗药物对T淋巴细胞及其亚群的影响。
应用推荐